Efficacy and Safety Study of Symbicort® Turbuhaler® Versus Oxis® Turbuhaler® in Chronic Obstructive Pulmonary Disease (COPD) Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

1,293

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

March 31, 2011

Study Completion Date

March 31, 2011

Conditions
Chronic Obstructive Pulmonary Disease
Interventions
DRUG

Budesonide/formoterol (Symbicort Turbuhaler)

2x160/4.5 microgram, inhalation, twice daily, 12 weeks

DRUG

Formoterol (Oxis Turbuhaler)

2 X 4.5 microgram, inhalation, twice daily, 12 weeks

Trial Locations (119)

Unknown

Research Site, Bangalore

Research Site, Mysore

Research Site, Trivandrum

Research Site, Indore

Research Site, Nagpur

Research Site, New Delhi

Research Site, Coimbatore

Research Site, Nagoya

Research Site, Okazaki

Research Site, Seto

Research Site, Toyota

Research Site, Toyota-shi

Research Site, Akita

Research Site, Fukuoka

Research Site, Yanagawa

Research Site, Gifu

Research Site, Takayama-shi

Research Site, Maebashi

Research Site, Ōta

Research Site, Hiroshima

Research Site, Asahikawa

Research Site, Obihiro

Research Site, Sapporo

Research Site, Tomakomai

Research Site, Himeji

Research Site, Itami

Research Site, Kobe

Research Site, Naka-gun

Research Site, Hitachi

Research Site, Tsukuba

Research Site, Kanazawa

Research Site, Sakaidechō

Research Site, Kagoshima

Research Site, Fujisawa

Research Site, Kawasaki-shi

Research Site, Yokohama

Research Site, Zama-shi

Research Site, Kochi

Research Site, Kyoto

Research Site, Matsusaka-shi

Research Site, Murata

Research Site, Sendai

Research Site, Chino-shi

Research Site, Matsumoto

Research Site, Isahaya-shi

Research Site, Nagaoka

Research Site, Saiki-shi

Research Site, Yufu-shi

Research Site, Kurashiki-shi

Research Site, Okayama

Research Site, Urasoe-shi

Research Site, Izumi-shi

Research Site, Kishiwada

Research Site, Moriguchi

Research Site, Osaka

Researche Site, Sakai-shi

Research Site, Saga

Research Site, Kitakatsushika-gun

Research Site, Koshigaya-shi

Research Site, Matsue

Research Site, Chūō

Research Site, Itabashi-ku

Research Site, Meguro City

Research Site, Minato-ku

Research Site, Setagaya City

Research Site, Shinagawa-ku

Research Site, Suginami-ku

Research Site, Sumida-ku

Research Site, Wakayama

Researche Site, San Fernando City

Research Site, Davao City

Research Site, Iloilo City

Research Site, Lipa City, Batangas

Research Site, Olongapo City

Research Site, Quezon City

Research Site, Bialystok

Research Site, Bydgoszcz

Research Site, Chodzież

Research Site, Jarosław

Research Site, Karpacz

Research Site, Krakow

Research Site, Lodz

Research Site, Loma

Research Site, Lublin

Research Site, Ostrów Wielkopolski

Research Site, Piła

Research Site, Poznan

Research Site, Ruda Śląska

Research Site, Słupca

Research Site, Tczew

Research Site, Torun

Research Site, Turek

Research Site, Włoszczowa

Research Site, Zabrze

Research Site, Zawadzkie

Research Site, Żnin

Research Site, Barnaul

Research Site, Kazan'

Research Site, Moscow

Research Site, Saint Petersburg

Research Site, Yekaterinburg

Research Site, Novosibirsk

Research Site, Vladikavkaz

Research Site, Ansan

Research Site, Incheon

Research Site, Seoul

Research Site, Chiayi City

Research Site, Kaohsiung City

Research Site, Keelung

Research Site, Taipei

Research Site, Dnipropetrovsk

Research Site, Donetsk

Research Site, Kyiv

Research Site, Poltava

Research Site, Uzhhorod

Research Site, Vinytsa

Research Site, Zaporozye

Research Site, Ho Chi Minh City

Research Site, Hanoi

Sponsors

Lead Sponsor

All Listed Sponsors
lead

AstraZeneca

INDUSTRY